FOXO Technologies Inc. (FOXO) Stock Price & Analysis
FOXO Technologies Inc. (FOXO) — price $0.1688 (0.00%), as of the Nov 18, 2026 trading session.
Educational signal · not a buy or sell recommendation · How to read this
FOXO Technologies Inc. · FOXO
FOXO Technologies Inc. is a healthcare technology platform focused on commercializing longevity science for the life insurance industry. The company offers FOXO Labs for integrating epigenetic biomarkers into underwriting and FOXO Life for proprietary and third-party life insurance products.
Price as of Nov 18, 2026
Key Statistics
Not scored: MoonshotScore covers actively traded US operating companies, not funds, preferred shares, warrants or thinly traded stocks.
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $0.1688 | |
| Change on the day | 0.00% | |
| 52-week range | $0.0204 – $1.50 | |
| Price / earnings (trailing) | 0.03 | |
| Shares traded on the day | 476 |
Price & events
Other perspectives
Council score for FOXO Technologies (FOXO): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Legends Council
1 lens, 1 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Nov 20, 2026
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Sep 9, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Sep 9, 2026, the Munger lens read the price at that time as undervalued against its own estimate of value.
Readings on this page are from Nov 20, 2026, except a card that shows its own read date.
What is FOXO Technologies (FOXO), and what does it report?
Short answer · as of
A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. FOXO Technologies Inc. (FOXO) is the company analyzed here. It employs 230 people and is led by Seamus Lagan. In Q2 FY2026 it reported revenue of $5M and net income of $8M.
What do the latest results show for FOXO Technologies (FOXO)?
Short answer · as of
The most recent reported quarter, Q2 FY2026, carried revenue of $5M.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q2 FY2026 | $5M | $8M | $0.09 (diluted) |
| Q1 FY2026 | $5M | -$1M | -$0.0005 (diluted) |
| Q4 FY2025 | $4M | -$9M | -$0.01 (diluted) |
| Q3 FY2025 | $4M | -$2M | -$0.29 (diluted) |
What are the financial strengths and risks for FOXO Technologies (FOXO)?
Short answer · as of
The distress and quality screens read Altman Z -7.35 · Piotroski F 6.
The records behind this page
Insider activity
Form 4 records via FMP · Most recent available transactions
- Transactions
- 12
- Identified insiders
- 3
- Purchases
- 0
- Sales
- 5
- Other transactions
- 7
Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held FOXO in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported FOXO in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
What has been published about FOXO Technologies (FOXO)?
- FOXO TECHNOLOGIES INC. ANNOUNCES AGREEMENTS TO ACQUIRE PREFERRED STOCK CARRYING MAJORITY VOTING POWER IN LUDWIG ENTERPRISES, INC.
- FOXO TECHNOLOGIES INC.’S SUBSIDIARY, MYRTLE RECOVERY CENTERS, INC., ANNOUNCES EXPANSION OF ITS FLAGSHIP FACILITY AND FOCUS ON SUBSTANCE USE DISORDER PATIENTS WITH RELATED MEDICAL CARE NEEDS
Common Questions About FOXO
These answers are editorial: 1 of these 8 answers is drawn from the FOXO research dossier (written Jun 15, 2026 by gemini-2.5-flash); the other 7 are question templates that restate figures shown above. Figures in this section are not part of the source register.
Is FOXO a good stock to buy?
Stock Expert AI does not rate FOXO buy, sell or hold. FOXO Technologies Inc. has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.
What is the FOXO stock price today?
The last price recorded for FOXO Technologies Inc. (FOXO), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What does FOXO Technologies Inc. do?
FOXO Technologies Inc. is a technology platform company that specializes in commercializing longevity science for the life insurance industry. It operates through two main platforms: FOXO Labs and FOXO Life.
What are the key factors to evaluate for FOXO?
Evaluate FOXO on fundamentals, analyst consensus, and risk factors. To weigh it, start with the trailing P/E under Price & valuation on this page. This engagement model is a long-term driver, fostering sustained growth over the next five to ten years. Not financial advice.
How frequently does FOXO data refresh on this page?
FOXO's price is the last quote we recorded, from the Nov 18, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.
What has driven FOXO's recent stock price performance?
FOXO Technologies Inc. (FOXO) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Innovative application of longevity science and epigenetic biomarkers in life insurance. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider FOXO overvalued or undervalued right now?
The trailing P/E of FOXO Technologies Inc. (FOXO) is listed under Price & valuation on this page. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research FOXO before investing?
Before investing in FOXO Technologies Inc. (FOXO), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 13 figures on this page — 9 from Financial Modeling Prep (FMP) and 4 with no recorded source. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com